<?xml version="1.0" encoding="UTF-8"?><rss xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:content="http://purl.org/rss/1.0/modules/content/" xmlns:atom="http://www.w3.org/2005/Atom" version="2.0"><channel><title><![CDATA[RSS Feed]]></title><description><![CDATA[RSS Feed]]></description><link>http://direct.ecency.com</link><image><url>http://direct.ecency.com/logo512.png</url><title>RSS Feed</title><link>http://direct.ecency.com</link></image><generator>RSS for Node</generator><lastBuildDate>Sat, 09 May 2026 20:52:24 GMT</lastBuildDate><atom:link href="http://direct.ecency.com/created/biotechindustry/rss.xml" rel="self" type="application/rss+xml"/><item><title><![CDATA[Novel Alzheimer's drug passes first phase of human testing]]></title><description><![CDATA[A drug that tackles toxic protein buildup in Alzheimer's disease in a novel way has passed phase 1 of clinical trials, which tests safety in humans. Source of shared Link]]></description><link>http://direct.ecency.com/dlike/@deathy/novel-alzheimers-drug-passes-first-phase-of-human-testing</link><guid isPermaLink="true">http://direct.ecency.com/dlike/@deathy/novel-alzheimers-drug-passes-first-phase-of-human-testing</guid><category><![CDATA[dlike]]></category><dc:creator><![CDATA[deathy]]></dc:creator><pubDate>Sat, 18 May 2019 17:36:24 GMT</pubDate><enclosure url="https://images.ecency.com/p/2923mN3pnd7PdDH5SNpadrba8HoUGiwWuxo3AXcL8S2GXniTFavLUXL7i4MhEZSSJoTa1UGRSiEDfnv1cShxYSHLymAvPKVQLoS5CbFjWMHLni?format=match&amp;mode=fit" length="0" type="false"/></item></channel></rss>